X-13603347-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3

The NM_015507.4(EGFL6):ā€‹c.431A>Gā€‹(p.Gln144Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000887 in 112,699 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.0000089 ( 0 hom., 1 hem., cov: 23)

Consequence

EGFL6
NM_015507.4 missense

Scores

8
3
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.68
Variant links:
Genes affected
EGFL6 (HGNC:3235): (EGF like domain multiple 6) This gene encodes a member of the epidermal growth factor (EGF) repeat superfamily. Members of this superfamily are characterized by the presence of EGF-like repeats and are often involved in the regulation of cell cycle, proliferation, and developmental processes. The gene product contains a signal peptide, suggesting that it is secreted; an EGF repeat region consisting of 4 complete EGF-like repeats and 1 partial EGF-like repeat, 3 of which have a calcium-binding consensus sequence; an arg-gly-asp integrin association motif; and a MAM domain, which is believed to have an adhesive function. This gene is expressed early during development, and its expression has been detected in lung and meningioma tumors. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.796

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
EGFL6NM_015507.4 linkuse as main transcriptc.431A>G p.Gln144Arg missense_variant 5/12 ENST00000361306.6 NP_056322.2
EGFL6NM_001167890.2 linkuse as main transcriptc.431A>G p.Gln144Arg missense_variant 5/12 NP_001161362.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
EGFL6ENST00000361306.6 linkuse as main transcriptc.431A>G p.Gln144Arg missense_variant 5/121 NM_015507.4 ENSP00000355126 A2Q8IUX8-1
EGFL6ENST00000380602.3 linkuse as main transcriptc.431A>G p.Gln144Arg missense_variant 5/121 ENSP00000369976 P4Q8IUX8-2

Frequencies

GnomAD3 genomes
AF:
0.00000887
AC:
1
AN:
112699
Hom.:
0
Cov.:
23
AF XY:
0.0000287
AC XY:
1
AN XY:
34839
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000277
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000557
AC:
1
AN:
179399
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
64007
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000742
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Cov.:
29
GnomAD4 genome
AF:
0.00000887
AC:
1
AN:
112699
Hom.:
0
Cov.:
23
AF XY:
0.0000287
AC XY:
1
AN XY:
34839
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000277
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000340
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 16, 2023The c.431A>G (p.Q144R) alteration is located in exon 5 (coding exon 5) of the EGFL6 gene. This alteration results from a A to G substitution at nucleotide position 431, causing the glutamine (Q) at amino acid position 144 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Pathogenic
0.24
D
BayesDel_noAF
Pathogenic
0.30
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.026
T;.
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Benign
0.84
T;T
M_CAP
Benign
0.053
D
MetaRNN
Pathogenic
0.80
D;D
MetaSVM
Pathogenic
0.83
D
MutationAssessor
Pathogenic
3.3
M;M
MutationTaster
Benign
1.0
D;D
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-3.9
D;D
REVEL
Pathogenic
0.86
Sift
Pathogenic
0.0
D;D
Sift4G
Uncertain
0.0030
D;D
Polyphen
1.0
D;D
Vest4
0.82
MutPred
0.38
Gain of solvent accessibility (P = 0.1154);Gain of solvent accessibility (P = 0.1154);
MVP
0.68
MPC
0.90
ClinPred
0.97
D
GERP RS
5.2
Varity_R
0.92
gMVP
0.85

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs751347794; hg19: chrX-13621466; API